维普期刊资源整合服务平台（V6.5）

688篇 您的检索式：作者名="Remuzzi"

选中清除导出查看参考文献查看引证文献引用追踪共35页首页上一页第1页下一页末页 /35 跳转

	题名	作者	年代	出处	被引量
1	WJSC 6^(th) Anniversary Special Issues(2):Mesenchymal stem cells Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes显示文摘Islet cell transplantation has therapeutic potential to treat type 1 diabetes,which is characterized by autoimmune destruction of insulin-producing pancreatic isletβcells.It represents a minimal invasive approach forβcell replacement,but long-term blood control is still largely unachievable.This phenomenon can be attributed to the lack of islet vasculature and hypoxic environment in the immediate post-transplantation period that contributes to the acute loss of islets by ischemia.Moreover,graft failures continue to occur because of immunological rejection,despite the use of potent immunosuppressive agents.Mesenchymal stem cells(MSCs)have the potential to enhance islet transplantation by suppressing inflammatory damage and immune mediated rejection.In this review we discuss the impact of MSCs on islet transplantation and focus on the potential role of MSCs in protecting islet grafts from early graft failure and from autoimmune attack.	Marina Figliuzzi Barbara Bonandrini Sara Silvani Andrea Remuzzi	2014	World Journal of Stem Cells2014，6，2：	10
2	Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial显示文摘	Dick de Zeeuw Rajiv Agarwal Michael Amdahl Paul Audhya Daniel Coyne Tushar Garimella Hans-Henrik Parving Yili Pritchett Giuseppe Remuzzi Eberhard Ritz Dennis Andress	2010	The Lancet . 2010 (9752)2010，，9752：	2
3	Pathophysiology of progressive nephropathies 显示文摘	Remuzzi G Bertain T	1998	N Engl J Med1998，339，20：	1
4	Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition显示文摘	Remuzzi G Ruggenenti P Perico N	2002	Ann Intern Med2002，136，8：	1
5	Platelet dysfunction inrenal failure 显示文摘	Boccardo P Remuzzi G Galbusera M	2004	Semin Thromb Hemost2004，30，5：	1
6	Albuminuria atherapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy 显示文摘	De Zeeuw D Remuzzi G Parving HH	2004	Circulation2004，110，8：	1
7	Transplant renal artery stenosis显示文摘	Bruno S Remuzzi G Ruggenenti P	2004	J Am Soc Nephrol2004，15，13：	1
8	Angiotensin converting enzyme inhibitors improves glomerular size-selectivety in IgA nephropathy显示文摘	Remuzzi A Perticucci E Reggenenti P	1991	Kid Int1991，39，：	1
9	Rituximab for idio- pathic membranous nephropathy 显示文摘	Remuzzi G Chiurchiu C Abbate M	2002	Lancet2002，360，9337：	1
10	Understanding the nature of renal disease progression显示文摘	Remuzzi G Ruggenenti P Benigni A	1997	Kidney Int1997，51，1：	1
11	Automatic generation of glomerular capillary topological organization 显示文摘	Antiga L Ene-Lordache B Remuzzi G	2001	Microvasc Res2001，62，3：	1
12	Understanding the nature of renal disease progression显示文摘	Remuzzi G Ruggenenti P Benigni A	1997	Kidney Int1997，51，1：	1
13	The role of renln-angiotensin-aldosterone system in the progression of chronic kidney disease 显示文摘	Remuzzi G Perico N Macia M	2005	Kidney Int Suppl2005，，99：	1
14	Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial显示文摘	Dick de Zeeuw Rajiv Agarwal Michael Amdahl Paul Audhya Daniel Coyne Tushar Garimella Hans-Henrik Parving Yili Pritchett Giuseppe Remuzzi Eberhard Ritz Dennis Andress	2010	The Lancet2010，，9752：	1
15	How renal cytokines and growth factor contribute to renal disease progression显示文摘	Remuzzi G	2001	AmJ Kidney Dis2001，37，2：	1
16	Pathophysiology of progressive nephropathies 显示文摘	Remuzzi G Bertani T	1998	N Engl J Med1998，39，20：	1
17	Albuminuria is a target for renoprotective therapy independent from blood pres- sure in patients with type 2 diabetic nephropathy: post hoc a- nalysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) tria显示文摘	Eijkelkamp WB Zhang Z Remuzzi G	2007	J Am Soc Nephrol2007，18，5：	1
18	Progression, remission, regression of chronic renal diseases 显示文摘	Ruggenenti R Schieppati A Remuzzi G	2001	Lancet2001，357，9268：	1
19	Early Experience with Dual Kidney Transplantation in Adults Using Expanded Donor Criteria显示文摘	Remuzzi G Grinyo J Ruggenenti P	1999	J Am Soc Nephrol1999，10，：	1
20	VonWillebrand factor cleaving protease(ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome显示文摘	Remuzzi G Galbusera M Noris M	2002	Blood2002，10，3：	1

返回顶部每页显示：

共35页首页上一页第1页下一页末页 /35 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示